They cut the dividend to save the fab, and the fab won't pay out until 2025.
Thesis: Siltronic is a classic 'peak capex, trough earnings' disconnect. They spent the cycle top building FabNext, which is now a margin anchor (depreciation/ramp costs) but will be a cash engine (50% EBITDA margin) when volume returns. The street hates the 2024 negative carry, but the asset is strategic and irreplaceable. You buy the capacity when it's a burden, to sell it when it's a bottleneck.
Verdict: LONG — Conviction: MEDIUM
Catalyst: Q3 2024 inventory normalization leading to 2025 pricing negotiations that reflect tight 300mm supply.
Key Risk: A 'lower for longer' recovery scenario pushing the inventory turn into 2025, forcing a distressed refinance of the 2024 funding gap.
The Tell: The dividend admission: 'If it is a negative EPS, it would mean zero dividend?' 'That means a zero dividend, yes.' They pivoted from shareholder return narrative to survival cash preservation instantly.
Friction Level: MODERATE_FRICTION — The 2024 'Gap Year'. Bulls see the capex cycle ending and operating leverage loading; Bears see a liquidity trap with negative cash flow and no control over the recovery timing.
Report not found
The report data is no longer available. Please return to the archive.